Who isn’t taking diabetes medication as prescribed? 10 March 2020 Managing blood glucose levels is a critical part of living well with type 2 diabetes but it can be difficult for many people. In fact, studies have shown that around half of all Australians have difficulty achieving their recommended HbA1c targets. One important factor in this is people not taking diabetes medication as prescribed. Now, thanks to a grant from the Diabetes Australia Research Program, the University of Sydney’s Dr Crystal Lee is trying to identify factors that are related to people not taking medication as regularly as they should. “Blood glucose lowering medications are an integral part of managing blood glucose levels, yet, according to a small-scale survey conducted in New South Wales, a third of the respondents were not taking their medications as regularly as they should,” Dr Lee said. “I’ll be using a number of different datasets joined together to identify any patterns of people who aren’t taking their medication as often as they are recommended. “This may help us work out whether this issue is more common in men or women, people of a certain age or socio-economic background. “Hopefully we will be able to get a better understanding of the impact of this as well. I’m really interested in understanding whether or not taking medication as often as prescribed leads to decreased hospitalisations and deaths.” Dr Lee thanked Diabetes Australia for funding diabetes research. “We need to understand how best to keep people healthy and out of hospital and the Diabetes Australia Research Program helps ensure Australia’s diabetes researchers can continue to do their important work.”
News 19 January 2026 National Diabetes Summit to convene at Federal Parliament Australia’s response to one of its most significant health challenges will come into sharp focus at Diabetes Australia’s National Diabetes... Continue Reading
News 16 January 2026 Wegovy to be listed on PBS The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended Wegovy (semaglutide) be subsidised through the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease and obesity. Diabetes Australia’s Group CEO... Continue Reading
Blog 15 January 2026 Five signs it’s time to book a diabetes telehealth appointment Accessing telehealth can be useful if you are newly diagnosed, you feel unwell, or if you are navigating a life transition. Continue Reading